Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Paroxetine augmentation with risperidone in therapy-resistant depression].

U Knopf1, P Hubrich-Ungureanu, J Thome

  • 1Zentralinstitut für Seelische Gesundheit, Mannheim.

Psychiatrische Praxis
|November 27, 2001
PubMed
Summary

A combination of paroxetine and risperidone effectively treated severe, therapy-resistant depression in a 71-year-old patient. This approach offered relief when multiple antidepressants failed over a decade.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 paranoia in a patient suffering from schizophrenic psychosis - a case report.

Psychiatry research·2020
Same author

Generalization of fear in post-traumatic stress disorder.

Psychophysiology·2019
Same author

Impact of adult attention deficit hyperactivity disorder and medication status on sleep/wake behavior and molecular circadian rhythms.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2019
Same author

Updated European Consensus Statement on diagnosis and treatment of adult ADHD.

European psychiatry : the journal of the Association of European Psychiatrists·2018
Same author

[Psychiatry Between Neurosciences and Social Sciences].

Fortschritte der Neurologie-Psychiatrie·2016
Same author

[A Short Summary of the Psychopathological Construct by Karl Leonhard].

Fortschritte der Neurologie-Psychiatrie·2016

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Neuroscience

Background:

  • Treatment-resistant depression (TRD) poses a significant clinical challenge, often requiring combination therapies.
  • Recurrent depressive episodes can severely impact quality of life and necessitate novel therapeutic strategies.

Observation:

  • A 71-year-old patient presented with a severe, therapy-resistant depressive episode.
  • The patient had a history of recurrent depression over ten years, with prior treatments proving ineffective.

Findings:

  • Successful management of the severe depressive episode was achieved using a combination of paroxetine and risperidone.
  • This combination therapy demonstrated efficacy in a case where monotherapy with various antidepressants had previously failed.

Related Experiment Videos

Implications:

  • This case highlights the potential utility of combining paroxetine with risperidone for managing complex cases of treatment-resistant depression.
  • Further research into combination pharmacotherapy may yield improved outcomes for patients with refractory depressive disorders.